Alector vs MediWound
Alector reported revenue of $21 million in fiscal 2025, 1.2 times MediWound's $17 million in fiscal 2025. Alector's revenue fell 79.1% in its latest year, and MediWound's fell 16.1%. Alector had an operating margin of -741.3%, against -149.0% at MediWound. Free cash flow was −$184 million at Alector and −$22 million at MediWound.
Side by side
| Alector | MediWound | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $21M | $17M |
| Revenue growth | −79.1% | −16.1% |
| Revenue growth a year, last 5 years | −0.1% | −4.9% |
| Gross margin | — | 19.2% |
| Operating margin | −741.3% | −149.0% |
| Net margin | −679.2% | −140.8% |
| Free cash flow | −$184M | −$22M |
| Free cash flow margin | −874.7% | −127.5% |
| Return on capital | — | — |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $0M | $0M |
| Change in diluted share count | 6.6% | 14.2% |
| Last close | $2.30 | $13.54 |
| P/E at the last close | 6.6× | — |
| Insider trades, last 12 months | sold $1.0 million | — |
| Piotroski F-score | 1 of 8 | — |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
AlectorMediWound
Operating margin
Percent of revenue
AlectorMediWound
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
AlectorMediWound
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Alector and MediWound pages.